261 related articles for article (PubMed ID: 27270765)
1. RAGE and glyoxalase in kidney disease.
Inagi R
Glycoconj J; 2016 Aug; 33(4):619-26. PubMed ID: 27270765
[TBL] [Abstract][Full Text] [Related]
2. Glycative stress and glyoxalase in kidney disease and aging.
Inagi R
Biochem Soc Trans; 2014 Apr; 42(2):457-60. PubMed ID: 24646260
[TBL] [Abstract][Full Text] [Related]
3. Glycative Stress and Its Defense Machinery Glyoxalase 1 in Renal Pathogenesis.
Hirakawa Y; Inagi R
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106734
[TBL] [Abstract][Full Text] [Related]
4. Potential of glycative stress targeting for cancer prevention.
Piperi C; Adamopoulos C; Papavassiliou AG
Cancer Lett; 2017 Apr; 390():153-159. PubMed ID: 28111136
[TBL] [Abstract][Full Text] [Related]
5. Receptor for advanced glycation end-products promotes premature senescence of proximal tubular epithelial cells via activation of endoplasmic reticulum stress-dependent p21 signaling.
Liu J; Huang K; Cai GY; Chen XM; Yang JR; Lin LR; Yang J; Huo BG; Zhan J; He YN
Cell Signal; 2014 Jan; 26(1):110-21. PubMed ID: 24113348
[TBL] [Abstract][Full Text] [Related]
6. The Glyoxalase System in Age-Related Diseases: Nutritional Intervention as Anti-Ageing Strategy.
Aragonès G; Rowan S; Francisco SG; Whitcomb EA; Yang W; Perini-Villanueva G; Schalkwijk CG; Taylor A; Bejarano E
Cells; 2021 Jul; 10(8):. PubMed ID: 34440621
[TBL] [Abstract][Full Text] [Related]
7. Defective interplay between mTORC1 activity and endoplasmic reticulum stress-unfolded protein response in uremic vascular calcification.
Panda DK; Bai X; Sabbagh Y; Zhang Y; Zaun HC; Karellis A; Koromilas AE; Lipman ML; Karaplis AC
Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1046-F1061. PubMed ID: 29357413
[TBL] [Abstract][Full Text] [Related]
8. Pentoxifylline mitigates renal glycoxidative stress in obese mice by inhibiting AGE/RAGE signaling and increasing glyoxalase levels.
Inacio MD; Costa MC; Lima TFO; Figueiredo ID; Motta BP; Spolidorio LC; Assis RP; Brunetti IL; Baviera AM
Life Sci; 2020 Oct; 258():118196. PubMed ID: 32763295
[TBL] [Abstract][Full Text] [Related]
9. Androgens Increase Accumulation of Advanced Glycation End Products in Granulosa Cells by Activating ER Stress in PCOS.
Azhary JMK; Harada M; Kunitomi C; Kusamoto A; Takahashi N; Nose E; Oi N; Wada-Hiraike O; Urata Y; Hirata T; Hirota Y; Koga K; Fujii T; Osuga Y
Endocrinology; 2020 Feb; 161(2):. PubMed ID: 32020188
[TBL] [Abstract][Full Text] [Related]
10. Activation of RAGE-dependent endoplasmic reticulum stress associates with exacerbated postmyocardial infarction ventricular arrhythmias in diabetes.
Liu Z; Zhang Y; Pan S; Qiu C; Jia H; Wang Y; Zhu H
Am J Physiol Endocrinol Metab; 2021 Mar; 320(3):E539-E550. PubMed ID: 33459180
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end products in the pathogenesis of chronic kidney disease.
Rabbani N; Thornalley PJ
Kidney Int; 2018 Apr; 93(4):803-813. PubMed ID: 29477239
[TBL] [Abstract][Full Text] [Related]
12. Impact of Advanced Glycation End products (AGEs) and its receptor (RAGE) on cancer metabolic signaling pathways and its progression.
Muthyalaiah YS; Jonnalagadda B; John CM; Arockiasamy S
Glycoconj J; 2021 Dec; 38(6):717-734. PubMed ID: 35064413
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology and therapeutics of premature ageing in chronic kidney disease, with a focus on glycative stress.
Hirakawa Y; Jao TM; Inagi R
Clin Exp Pharmacol Physiol; 2017 Dec; 44 Suppl 1():70-77. PubMed ID: 28467603
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic targeting of advanced glycation end-products in age-related diseases.
Rowan S; Bejarano E; Taylor A
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3631-3643. PubMed ID: 30279139
[TBL] [Abstract][Full Text] [Related]
15. Cellular mechanisms and consequences of glycation in atherosclerosis and obesity.
López-Díez R; Shekhtman A; Ramasamy R; Schmidt AM
Biochim Biophys Acta; 2016 Dec; 1862(12):2244-2252. PubMed ID: 27166197
[TBL] [Abstract][Full Text] [Related]
16. AGE/RAGE signaling-mediated endoplasmic reticulum stress and future prospects in non-coding RNA therapeutics for diabetic nephropathy.
Pathomthongtaweechai N; Chutipongtanate S
Biomed Pharmacother; 2020 Nov; 131():110655. PubMed ID: 32853909
[TBL] [Abstract][Full Text] [Related]
17. Knockout of receptor for advanced glycation end-products attenuates age-related renal lesions.
Teissier T; Quersin V; Gnemmi V; Daroux M; Howsam M; Delguste F; Lemoine C; Fradin C; Schmidt AM; Cauffiez C; Brousseau T; Glowacki F; Tessier FJ; Boulanger E; Frimat M
Aging Cell; 2019 Apr; 18(2):e12850. PubMed ID: 30794349
[TBL] [Abstract][Full Text] [Related]
18. Proteostasis in endoplasmic reticulum--new mechanisms in kidney disease.
Inagi R; Ishimoto Y; Nangaku M
Nat Rev Nephrol; 2014 Jul; 10(7):369-78. PubMed ID: 24752014
[TBL] [Abstract][Full Text] [Related]
19. Do all roads lead to the Rome? The glycation perspective!
Ahmad S; Akhter F; Shahab U; Rafi Z; Khan MS; Nabi R; Khan MS; Ahmad K; Ashraf JM; Moinuddin
Semin Cancer Biol; 2018 Apr; 49():9-19. PubMed ID: 29113952
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of glyoxalase 1 by mangiferin prevents diabetic nephropathy progression in streptozotocin-induced diabetic rats.
Liu YW; Zhu X; Zhang L; Lu Q; Wang JY; Zhang F; Guo H; Yin JL; Yin XX
Eur J Pharmacol; 2013 Dec; 721(1-3):355-64. PubMed ID: 24036348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
